CX Institutional’s Elanco Animal Health ELAN Stock Holding History

CX Institutional’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-145	Closed	-$3K	–	1590
2026 Q1	$3K	Buy	+145	New	+$3.54K	﹤0.01%	1399

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

CX Institutional's ELAN Position: Q2 2026 in Review

CX Institutional sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 145 shares — an estimated $3K sold.

CX Institutional first reported a position in ELAN in Q1 2026 and held it in 1 quarter. The position peaked at $3K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

CX Institutional reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
CX Institutional sold 145 Elanco Animal Health shares in Q2 2026, an estimated $3K.
CX Institutional first reported a position in Elanco Animal Health in Q1 2026 and held it in 1 quarter.
CX Institutional's Elanco Animal Health position peaked at $3K in Q1 2026.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.